Gut Podcast

All Episodes (98)

From new to old

From new to old From old to new

1. 

   1. Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis

   Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Julia Mayerle and Dr Simon Sirtl from the Department of Medicine II, LMU University Hospital, Munich, Germany, on the paper "Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis" published in paper copy in Gut in October 2023 and available online: https://gut.bmj.com/content/72/10/1919 Please subscribe

   Oct 02,2023 19:09
2. 

   2. Rome consensus on gut microbiota and faecal microbiota transplantation in IBD

   Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Loris Lopetuso, Department of Medicine and Ageing Sciences, University of Chieti-Pescara, Italy, on the paper "The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease", published in paper copy in Gut in September 2023, and available online:https://gut.bmj.com/conten

   Sep 01,2023 13:55
3. 

   3. The therapeutic potential of fasting

   Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Thomas Marjot, Hepatology SpR from the Oxford Liver Unit in Oxford University Hospitals and also a Wellcome Trust Clinical Research Training Fellow at the University of Oxford based at the Oxford Centre for Diabetes, Endocrinology and Metabolism, UK, on the paper "Timing of energy intake and the therapeutic potential of intermittent fasting

   Aug 01,2023 12:44
4. 

   4. Helicobacter pylori promotes colorectal carcinogenesis

   Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Markus Gerhard from the Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich, Germany, on the paper "Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature" published in paper copy in Gut in

   Jul 03,2023 11:42
5. 

   5. Single-cell transcriptomics sheds new light on pancreas biology and disease

   Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Kathy DelGiorno, from the Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA, on the paper 'It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease' published in paper copy in Gut in June 2023 and available online

   Jun 01,2023 09:55
6. 

   6. Counteracting the harm of dietary emulsifiers with Akkermansia muciniphila

   Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Benoit Chassaing, group leader from the “Mucosal microbiota in chronic inflammatory diseases” Team at INSERM and the Université Paris Cité, Paris, France, on the paper 'Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism' published in paper copy in Gut in May 2023 and av

   Apr 27,2023 15:34
7. 

   7. Antibiotic use as a risk factor for IBD

   Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Tine Jess, from the Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, and Department of Gastroenterology and Hepatology, Aalborg University, Aalborg, Denmark, and Dr Adam S Faye, from the Department of Medicine and Population Health, New York University Langone Health, New York, USA, on th

   Mar 22,2023 17:48
8. 

   8. Predicting disease progression in bridging fibrosis and cirrhosis with liver stiffness

   Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Rohit Loomba, Professor of Medicine in the Division of Gastroenterology, and Adjunct Professor in the Division of Epidemiology at the University of California San Diego, La Jolla, California, USA on the paper 'Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis' published

   Feb 27,2023 09:12
9. 

   9. Assessing the impact of dietary fibre on bile acid transformation by gut bacteria in mice

   Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Fredrik Bäckhed, The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden on the paper '6α-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice' published in paper copy in Gut in February 2023, and availabl

   Jan 27,2023 10:13
10. 

    10. Autoimmune gastritis: cancer risk in consistently tested H. pylori-negative patients

    Dr Philip Smith, Digital and Education Editor of Gut, and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Professor Massimo Rugge, Pathologist at Padova University, Italy, and Adjunct Professor of Medicine at the Baylor College of Medicine in Houston, Texas, USA; and Ms Ludovica Bricca, a student at Padova University, and the youngest researcher involved in the study. They are interviewed on the paper 'Autoimmune gastritis: long-term natural history in na

    Jan 04,2023 14:52
11. 

    11. FMT-AID trial shows effectiveness in inducing remission of ulcerative colitis

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Vineet Ahuja who is from the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India, on the paper 'Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to mode

    Nov 28,2022 13:44
12. 

    12. Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis

    Endoscopic pyloromyotomy (G-POEM) is a minimally invasive treatment option with promising uncontrolled outcome results in patients with gastroparesis.Dr Philip Smith, Digital and Education Editor of Gut, interviews Professor Jan Martinek, from the Department of Hepatogastroenterology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic, about his paper on this topic. The article titled 'Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot

    Nov 01,2022 16:00
13. 

    13. Climate change: a survey of global gastroenterology society leadership

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Desmond Leddin, who is from the Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada, on the paper 'Climate change: a survey of global gastroenterology society leadership' published in paper copy in Gut in October 2022 and available online at: https://gut.bmj.com/content/71/10/1929Please subscribe to the Gut Podcast via a

    Oct 10,2022 16:29
14. 

    14. Management of Helicobacter pylori infection — the Maastricht VI/Florence Consensus Report

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Peter Malfertheiner, Gastroenterologist, who is senior Professor of Medicine at the Ludwig Maximilian University of Munich, Munich, Germany, on the paper 'Management of Helicobacter pylori infection—the Maastricht VI/Florence Consensus Report' published in paper copy in Gut in September 2022 and online at: https://gut.bmj.com/content/71/9/1724

    Sep 08,2022 12:42
15. 

    15. Kyoto international consensus report on the gastro-oesophageal junction

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Sugano, Department of Medicine, Jichi Medical University, Tochigi, Japan, about the paper 'Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction'. The article is published in paper copy in Gut in August 2022, and available online: https://gut.bmj.com/content/71/8/1488.Plea

    Aug 18,2022 12:24
16. 

    16. A faecal microbiota signature with high specificity for pancreatic cancer

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Professor Peer Bork, Director of the Heidelberg site of the European Molecular Biology Laboratory Heidelberg, Baden, Germany on the paper 'A faecal microbiota signature with high specificity for pancreatic cancer' published in paper copy in Gut in July 2022, and available online: https://gut.bmj.com/content/71/7/1359Please subscribe to the Gut Podcast

    Jul 18,2022 06:51
17. 

    17. PICaSSO Histologic Remission Index in ulcerative colitis: a novel simplified histological score

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Dr Marietta Iacucci, Associate Professor in Gastroenterology, Institute of Immunology and Immunotherapy, University of Birmingham and Consultant Gastroenterologist, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom, on the paper "‘PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simp

    Jun 20,2022 10:33
18. 

    18. Next-generation sequencing of bile cell-free DNA for early detection of malignant biliary strictures

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Dr Maria Arechederra, young researcher at the Hepatology Program in the Center for Applied Medical Research (CIMA) from the University of Navarra in Pamplona, Spain, on the paper "Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures" which is published in paper copy in Gut in June 2022,

    Jun 06,2022 10:02
19. 

    19. Endoscopic full-thickness plication for the treatment of PPI-dependent GERD

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Rakesh Kalapala, Senior Consultant Gastroenterologist & Therapeutic Endoscopist, Head of GI Motility Lab, Director of Endoscopy at the Center for Obesity & Metabolic Therapy, Member of the International Bariatric and Metabolic Endoscopy Committee, Asian Institute of Gastroenterology Hospitals, Hyderabad, India on the paper 'Endoscopic full-thickness

    Mar 30,2022 07:00
20. 

    20. Dysosmobacter welbionis, a new human commensal bacterium preventing diet-induced obesity

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Patrice Cani, Louvain Drug Research Institute, WELBIO, Metabolism and Nutrition, UCLouvain, Brussels, Belgium and Emilie Moens de Hase a PhD student in the same institution. This Gut podcast is focused on the paper "Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice" which is

    Feb 28,2022 11:39
21. 

    21. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Pg-LPS

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Lu from the Department of Respiratory Care, College of Medicine, Fu Jen Catholic University, Taiwan, and Drs Lai and Dr Lin from the Department of Medical Biotechnology and Laboratory Science, and Microbiota Research Center, College of Medicine, Chang Gung University, Taiwan. The Gut podcast is focused on the paper "Gut microbiota modulates COPD pathogenesis: role

    Jan 28,2022 11:36
22. 

    22. Proton pump inhibitors and risk of colorectal cancer

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Laurent Azoulay and Dr Devin Abrahami, from the Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, and McGill University, Montreal, Canada. Dr. Abrahami is now a postdoctoral fellow at the Brigham and Women’s Hospital and Harvard Medical School. This Gut podcast is focused on the paper "Proton pump inhibitors and risk of colorectal cancer

    Jan 06,2022 07:03
23. 

    23. Sugar-sweetened beverage intake and risk of early-onset colorectal cancer among women

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Professor Cao, Associate Professor of Surgery, Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. This Gut podcast is focused on the paper "Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women", which is published in paper copy in Gut i

    Nov 25,2021 07:35
24. 

    24. Diet quality and risk and severity of COVID-19: a prospective cohort study

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Professor Andrew Chan, Harvard Medical School, Boston, USA. This podcast is focused on the paper "Diet quality and risk and severity of COVID-19: a prospective cohort study", published in paper copy in Gut in November 2021. Link to the paper: https://gut.bmj.com/content/70/11/2096

    Oct 29,2021 07:26
25. 

    25. Helicobacter pylori resistance to antibiotics in Europe

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Professor Megraud, University of Bordeaux, France. The podcast is focused on the paper "Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community”, which is published in paper copy in Gut in October 2021.Link to the paper: https://gut.bmj.com/content/70/10/1815

    Oct 01,2021 06:32
26. 

    26. Blue poo: impact of gut transit time on the gut microbiome using a novel marker

    In this podcast, we'll explore how eating a ‘blue’ muffin is an inexpensive and scalable technique allowing the measurement of transit time. The method was used to assess the relationship between gut transit time and the human gut microbiome, in a study published in paper copy in Gut, in September 2021."Blue poo: impact of gut transit time on the gut microbiome using a novel marker" is accessible here: https://gut.bmj.com/content/70/9/1665Dr Philip Smith, Digital and Education Editor of Gut and

    Sep 08,2021 10:31
27. 

    27. Long-term dietary patterns associated with inflammatory features of the gut microbiome

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Laura Bolte dietitian and PhD student from the Department of Gastroenterology and Hepatology and the Department of Genetics, University of Groningen and University Medical Centre Groningen, Groningen, The Netherlands and Professor Rinse Weersma from the Department of Gastroenterology and Hepatology at the University of Groningen and University Medical Centre Groningen

    Jul 01,2021 14:47
28. 

    28. Association between Brachyspira and irritable bowel syndrome with diarrhoea

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Gunnar C. Hansson from the Mucin Biology Groups, Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Sweden. The Gut podcast is focussed on the paper "Association between Brachyspira and irritable bowel syndrome with diarrhoea" which is published in paper copy in Gut in June 2021.Related or relevant article: https://gut.bmj.com/con

    Jun 01,2021 13:07
29. 

    29. Effect of IBD medications on COVID-19 outcomes

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Dr Ryan Ungaro, who is an Assistant Professor at Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA. The podcast is focussed on ‘Effect of IBD medications on COVID-19 outcomes: results from an international registry’ published in paper copy in Gut in April 2021.Related or relevant article: https://gut.bmj.com/content/70/4/725

    May 12,2021 13:33
30. 

    30. CLARITY IBD: Anti-SARS-CoV-2 antibody and vaccination responses in patients treated with infliximab

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Tariq Ahmad and Dr Nick Kennedy, both from the Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, UK. This special Gut podcast is focused on ‘Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab’ which is published in paper copy in Gut in May 2021 and the recently published paper ‘Infliximab is as

    Apr 23,2021 19:32
31. 

    31. Long-term instability of the intestinal microbiome and its associations

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Fabian Frost who is a clinical scientist, internal medicine specialist and gastroenterologist in training working at the Department of Medicine A, University Medicine Greifswald, Germany. The podcast is focussed on ‘Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaire

    Apr 06,2021 13:26
32. 

    32. Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Nathanson, the Gladys Phillips Crofoot Professor of Medicine and Cell Biology at Yale University and the Director of the Yale Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA. The podcast is focussed on "Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis", published in paper copy in

    Mar 10,2021 11:17
33. 

    33. Screening and eradication of Helicobacter pylori for gastric cancer prevention

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Jyh-Ming Liou, Professor of Gastroenterology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. The podcast is focussed on "Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus" published in paper copy in Gut in Decembe

    Feb 01,2021 12:43
34. 

    34. European Registry on Helicobacter pylori management (Hp-EuReg)

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Gisbert from the Gastroenterology Department, University Hospital of La Princesa, Madrid, Spain. The podcast is focused on "European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients" published in paper copy in Gut in January 2021, and o

    Jan 09,2021 07:01
35. 

    35. Driving the efficacy of prebiotic intervention in obese patients

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Delzenne, President of the Louvain Drug Research Institute, at the UCLouvain, Brussels, Belgium. The podcast is focused on "Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients" published in paper copy in Gut in November 2020, and online at: https://gut.bmj.com/content/69/11/1975

    Nov 15,2020 11:45
36. 

    36. Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Dr Rima Chakaroun who is a Clinician Scientist, Resident physician at the University Hospital in Leipzig, Germany, specialising in Endocrinology and Metabolic disease and a postdoctoral researcher and clinical investigator working on microbiome signatures in obesity in gut and beyond. The podcast is focused on "Adipose tissue derived bacteria are associated with infla

    Oct 19,2020 19:20
37. 

    37. Global burden of oesophageal and gastric cancer by histology and subsite in 2018

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Dr Melina Arnold from the Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. The podcast is focussed on "Global burden of oesophageal and gastric cancer by histology and subsite in 2018" published in paper copy in Gut in September 2020https://gut.bmj.com/content/69/9/1564

    Sep 26,2020 08:53
38. 

    38. Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Silvia Sookoian, who is Head of the Department of Clinical & Molecular Hepatology and Vice-Chair of Institute of Medical Research, at the Institute of Medical Research, Strategic Alliance between the National Scientific and Technical Research Council (CONICET)and the School of Medicine, University of Buenos Aires, Argentina; and Principal Investigator of the

    Aug 13,2020 13:02
39. 

    39. Efficacy of FMT for patients with IBS in a randomised, double-blind, placebo-controlled study

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Madgy El-Salhy, who is a Professor of Gastroenterology at Bergen University and Consultant Gastroenterologist at Stord Hospital, Norway, on the paper ‘Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study’ published in paper copy in Gut in May 2020 - https://gut.bmj.co

    Jul 19,2020 13:28
40. 

    40. Infants born to mothers with IBD present with altered gut microbiome

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Inga Peter, who is a Professor in the Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, on "Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice" published in paper copy in Gut in January 2020. Link to the paper: https://gut.bmj.c

    Jun 22,2020 08:03
41. 

    41. Mediterranean diet intervention alters the gut microbiome in older people

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Paul O'Toole; who is Professor of Microbial Genomics, Head of School of Microbiology and Principal Investigator in APC Microbiome Ireland, an SFI funded centre at University College Cork, Ireland, on "Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention

    May 31,2020 14:55
42. 

    42. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Jacques Bergman who is Professor of Gastrointestinal Endoscopy at the Amsterdam University Medical Center, Amsterdam on "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study" published in paper copy in Gut in February 2020. Accessible o

    May 03,2020 12:18
43. 

    43. British Society of Gastroenterology guidance for management of IBD during the Covid-19 pandemic

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Cathryn Edwards, BSG President and Consultant Gastroenterologist at Torbay Hospital, Devon and Dr Nick Kennedy, Consultant Gastroenterologist, Royal Devon and Exeter NHS Foundation Trust on the British Society of Gastroenterology response to the coronavirus pandemic and on the guidance produced by a team of UK IBD Specialists entitled ‘BSG guidance for management

    Apr 22,2020 23:07
44. 

    44. Global patterns and trends in colorectal cancer incidence in young adults

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Ms Rebecca Siegel, Scientific Director of Surveillance Research at the American Cancer Society. Ms Rebecca Siegel is first author on the paper 'Global patterns and trends in colorectal cancer incidence in young adults' published in Gut in December 2019.Read the article - https://gut.bmj.com/content/68/12/2179

    Mar 29,2020 06:27
45. 

    45. Guidelines on the management of inflammatory bowel disease in adults

    Dr Christopher Lamb, Clinical Intermediate Fellow at Newcastle University and Honorary Consultant in Gastroenterology at the Newcastle upon Tyne Hospitals NHS Foundation Trust discusses the BSG guidelines on the management of inflammatory bowel disease in adults with Associate Editor of GUT Dr Philip Smith.Read the article: https://gut.bmj.com/content/68/Suppl_3/s1

    Nov 21,2019 09:28
46. 

    46. European evidence-based guidelines on pancreatic cystic neoplasms

    Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are lacking. The guideline discussed in this podcast is a joint initiative of the European Study Group on Cystic Tumours of the Pancreas, United European Gastroenterology, European Pancreatic Club, European-African Hepato-Pancreato-Biliary Association, European Digestive Surgery, and the European Society of Gastrointestinal Endoscopy.Listen to the discussion between the Education Editor of Gut, Mairi McLean, and Mar

    Aug 20,2018 13:27
47. 

    47. Viral transfer during FMT linked to better outcomes in recurrent C. diff bacterial infections

    Clostridium difficile (C. difficile, C. diff or CDI) is a bacterium associated with the intake of antibiotics which causes diarrhoea. It is easily spread to others, both in hospital and a household environments.C. Diff infections are generally treated with antibiotics. Recurrent infection is successfully treated with faecal microbiota transplantation (FMT), however the underlying mechanism of action is not well defined. This study identified a key role of the virome within the transferred stool

    May 11,2018 17:36
48. 

    48. Colorectal cancer: research prioritisation needed in third most lethal malignancy worldwide

    Prioritising research and funding could have a significant impact on reducing colorectal cancer disease burden over the next 5 years. The conclusions are included in a study recently published by Gut titled “Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer” and expanded in this podcast. In conversation with the journal’s Education Editor Mairi McLean, the leading author of the study, Mark Lawler,

    Mar 15,2018 19:43
49. 

    49. Development of an FGF19-based chimeric molecule to promote fatty liver regeneration

    In this episode Mairi McLean, Associate Editor of Gut journal, talks to Matias Avila and Carmen Berasai, University of Navarra, Pamplona, Spain. They discuss their published paper "Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration".Full article >> http://gut.bmj.com/content/66/10/1818.info

    Nov 26,2017 23:54
50. 

    50. Feeding the microbiota: transducer of nutrient signals for the host

    In this episode Mairi McLean, Associate Editor of Gut journal, talks to Fergus Shanahan, Professor and Chair of the Department of Medicine at University College Cork. They discuss his recent paper in Gut entitled "Feeding the microbiota: transducer of nutrient signals for the host"Full text - http://gut.bmj.com/content/early/2017/06/29/gutjnl-2017-313872

    Oct 29,2017 23:52
51. 

    51. Dietary emulsifiers directly alter human microbiota composition

    In this episode Mairi McLean, Associate Editor of Gut journal, talks to Benoit Chassaing, Georgia State University - Center for Inflammation, Immunity and Infection, about his recently published paper "Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation".Full paper>> http://gut.bmj.com/content/66/8/1414

    Aug 16,2017 17:06
52. 

    52. Faecal microbiota transplantation in clinical practice

    In this episode Mairi McLean, Associate Editor of Gut journal, talks to Giovanni Cammarota and Gianluca Ianiro from the Agostino Gemelli University. They discuss the April editors choice paper "European consensus conference on faecal microbiota transplantation in clinical practice".Full paper >> http://gut.bmj.com/content/early/2017/01/13/gutjnl-2016-313017

    Jun 20,2017 17:57
53. 

    53. BMP-9 interferes with liver regeneration and promotes liver fibrosis

    In this episode Mairi McLean, Education Editor for Gut, talks to Dr Katja Breitkopf-Heinlein, Medical Faculty Mannheim, Heidelberg University, about her recently published paper "BMP-9 interferes with liver regeneration and promotes liver fibrosis".Full paper >> http://gut.bmj.com/content/66/5/939

    May 31,2017 16:49
54. 

    54. A systematic review of isolated colonic Crohn’s disease: the third IBD?

    In this podcast Mairi McLean talks to Professor Jon Rhodes about his recently published paper "Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?"Full paper >> http://gut.bmj.com/content/66/2/362

    Feb 27,2017 17:05
55. 

    55. Gut microbiome and liver diseases

    In this episode Mairi McLean talks to Herbert Tilg about his recently published paper "Gut microbiome and liver diseases".Full paper >> http://gut.bmj.com/content/65/12/2035.long

    Feb 02,2017 24:41
56. 

    56. Antibiotics as deep modulators of gut microbiota: between good and evil.

    In this podcast Mairi McLean interviews Dr Gianluca Ianiro about the editors choice paper "Antibiotics as deep modulators of gut microbiota: between good and evil."Full paper >> http://gut.bmj.com/content/65/11/1906.full?sid=4929814b-b6f1-43d2-9af1-964357aa664c

    Jan 04,2017 17:24
57. 

    57. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease

    In this episode Mairi McLean talks to Professor Fock about his recently published paper; "Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus"Full paper >> http://gut.bmj.com/content/65/9/1402.full?sid=13ba6d1c-8c84-4ae9-9cd3-0bab0fa2b3a9

    Oct 19,2016 23:16
58. 

    58. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma

    In this track Mairi McLean talks to Hasim El-Serag about the recent paper "Surveillance endoscopy is associated with improved outcomes of oesophagealadenocarcinoma detected in patients with Barrett's oesophagus."

    Sep 22,2016 27:17
59. 

    59. Live birth and adverse birth outcomes in women with ulcerative colitis and Crohn’s disease

    In this podcast Dr Mairi McLean talks to Dr Sonia Friedman about the May editors choice paper "Live birth and adverse birth outcomes in women with ulcerative colitis and Crohn's disease receiving assisted reproduction: a 20-year nationwide cohort study".Full text > http://gut.bmj.com/content/65/5/767.full

    Jun 17,2016 13:02
60. 

    60. GLP-1 based therapies: clinical implications for gastroenterologists

    In this podcast Dr Mairi McLean talks to Dr Mark Smits and Dr Djuna Cahen about their editors choice paper "GLP-1 based therapies: clinical implications for gastroenterologists"

    May 24,2016 22:52
61. 

    61. Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis

    In this podcast Dr Mairi McLean talks to Professor Dirk Haller about his editors choice paper "Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence."Read the full paper >> http://gut.bmj.com/content/65/2/225.full

    Mar 23,2016 15:37
62. 

    62. Mesalazine and thymoquinone attenuate intestinal tumour development in mice

    In this podcast Dr Mairi McLean talks to Dr Christoph Gasche about his editors choice paper "Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice."Full paper >> http://gut.bmj.com/content/64/12/1905.full

    Mar 08,2016 19:06
63. 

    63. Effects of bowel cleansing on the intestinal microbiota

    In this podcast Dr Mairi McLean talks to Dr Joanna Jalanka about her recently published article in Gut entitled "Effects of bowel cleansing on the intestinal microbiota".They discuss what was already known in the field and what has since been discovered, and how long these effects last and how the microbiota were measured.

    Jan 25,2016 11:11
64. 

    64. Development of an enhanced human gastrointestinal epithelial culture system

    Mairi McLean talks to Thaddeus S Stappenbeck, Department of Pathology and Immunology, Washington University School of Medicine, about his paper: Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays.Read the full paper: http://goo.gl/xeWDHz

    Aug 28,2015 22:10
65. 

    65. Helicobacter pylori targets cancer-associated apical-junctional constituents

    Helicobacter pylori strains that express the a protein that increases the risk of gastric cancer. However, the precise mechanisms through which the cancer risk is heightened have not been fully investigated and understood.In this podcast Dr Mairi McLean talks to Dr Lydia Wroblewski from the Vanderbilt University School of Medicine about the study her group conducted to define mechanisms through which H. pylori modulates expression of the cancer-associated tight junction protein claudin-7.To read

    Jun 16,2015 14:09
66. 

    66. Diagnosis and management of acute kidney injury in patients with cirrhosis

    Acute renal failure (ARF) is a common complication in patients with decompensated cirrhosis. The traditional diagnostic criteria of renal failure in these patients were proposed in 1996 and have been refined in subsequent years. More recently the International Club of Ascites (ICA)redefined the criteria to reach a new definition of acute kidney injury (AKI) in patients with cirrhosis. Dr Mairi McLean speaks to lead author Professor Paolo Angeli from the University of Padova about the scientific

    May 29,2015 13:16
67. 

    67. Demonstration of the usefulness of epigenetic cancer risk prediction

    Epigenetic alterations accumulate in normal-appearing tissues of patients with cancer, producing an epigenetic field defect. Cross-sectional studies show that the degree of the defect may be associated with risk in some types of cancer, especially cancers associated with chronic inflammation. Dr Mairi McLean speaks to Dr Toshikazu Ushijima about his study investigating these defects and the association with gastric cancer.

    Apr 27,2015 16:11
68. 

    68. XIAP variants in male Crohn’s disease

    The genetic basis of inflammatory bowel disease (IBD) is incompletely understood, and the aim of a recent study in Gut was to identify rare genetic variants involved in the pathogenesis of IBD.Mairi McLean speaks to authors Sebastian Zeissig, Department of Internal Medicine I, University Medical Center Schleswig-Holstein, and Andre Franke, Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, to hear what they found.Read the full paper:http://gut.bmj.com/content/64/1/6

    Feb 10,2015 27:34
69. 

    69. Cell lineage distribution atlas reveals heterogeneous gland populations in the gastric antrum

    The glands of the stomach body and antral mucosa contain a complex compendium of cell lineages. In lower mammals, the distribution of oxyntic glands and antral glands define the anatomical regions within the stomach. Now a paper in Gut has examined in detail the distribution of the full range of cell lineages within the human stomach. Mairi McLean talks to authors James Goldenring, Eunyoung Choi and Joseph Roland, all Vanderbilt University School of Medicine, Nashville, Tennessee.Read the full p

    Jan 02,2015 14:26
70. 

    70. Classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease

    Mairi McLean talks to Krisztina Gecse about the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease.Read the related article:http://gut.bmj.com/content/63/9/1381.full

    Oct 24,2014 20:28
71. 

    71. Update on basic and clinical aspects of eosinophilic oesophagitis

    The identification of a distinct syndrome, designated eosinophilic oesophagitis (EoE), with its own clinical and histopathological characteristics, was first described in the early 1990s. Meanwhile intense research has uncovered many molecular, immunological and clinical aspects of this chronic-inflammatory disorder. In this podcast, Mairi McLean talks to Professor Alex Straumann, Swiss EoE Clinic and EoE Research Network, about the basic and clinical insights of EoE gathered during the last few

    Sep 25,2014 25:39
72. 

    72. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition

    Inflammatory bowel disease is driven by a seemingly aberrant immune response to the gut microbiota with disease development dictated by genetics and environmental factors. A model exemplifying this notion is work by Andrew Gewirtz, Center for Inflammation, Immunity, & Infection, Georgia State University, and colleagues, demonstrating that colonisation of adherent-invasive Escherichia coli (AIEC) during microbiota acquisition drove chronic colitis in mice lacking the flagellin receptor TLR5 (T5KO

    Aug 21,2014 15:44
73. 

    73. Besifovir versus entecavir in Asian patients with chronic hepatitis B

    Despite the success of hepatitis B virus vaccination in preventing new infection in endemic areas, chronic hepatitis B still poses a heavy burden globally. There are approximately 350 million carriers in the world, with an estimated 60 000 persons dying annually of hepatitis B-related cirrhosis and hepatocellular carcinoma.In a study recent published in Gut, Professor Man-Fung Yuen, Department of Medicine, The University of Hong Kong, and colleagues, report the results of viral suppression and s

    Aug 15,2014 09:29
74. 

    74. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea

    Mairi McLean talks to Robin Spiller, NIHR Nottingham Digestive Diseases Biomedical Research Unit, and David Tooth, School of Biomedical Sciences, University of Nottingham, about their paper: Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit.Read the full article: http://goo.gl/0OIP34

    Jun 09,2014 20:13
75. 

    75. Recent advances in clinical practice challenges and opportunities in the management of obesity

    Mairi McLean talks to Andres Acosta and Barham K Abu Dayyeh, both Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, about their review on the management of obesity.Read the full paper: http://goo.gl/V37xaq

    Apr 29,2014 23:39
76. 

    76. Amniotic stem cell treament for necrotic enterocolitis

    Necrotising enterocolitis (NEC) remains one of the primary causes of morbidity and mortality in neonates and alternative strategies are needed. Stem cells have become a therapeutic option for other intestinal diseases, which share some features with NEC. Along with colleagues, Simon Eaton and Paolo De Coppi, both from University College London Institute of Child Health, have tested the hypothesis that amniotic fluid stem (AFS) cells exerted a beneficial effect in a neonatal rat model of NEC.Mair

    Feb 21,2014 24:24
77. 

    77. British Society of Gastroenterology guidelines on diagnosing and managing Barrett’s oesophagus

    Gut's education editor Mairi McLean discusses highlights from the guidelines on the diagnosis and management of Barrett's oesophagus with authors Rebecca Fitzgerald and Massimiliano di Pietro, both from the MRC Cancer Unit, University of Cambridge.Read the full paper here: http://bit.ly/1kkPkVW

    Jan 31,2014 24:02
78. 

    78. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients

    Mairi McLean talks to Markus Peck-Radosavljevic, Division of Gastroenterology & Hepatology, Medical University Vienna, about his study looking at carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.Read the full paper here: bit.ly/1991biw

    Nov 29,2013 19:21
79. 

    79. A systematic approach to therapeutic target selection in oesophago-gastric cancer

    Mairi McLean talks to Anna Paterson and Rebecca Fitzgerald, both MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Cambridge, about their study investigating whether a receptor tyrosine kinase (RTK) array could be used to select the most effective therapeutic strategies in molecularly heterogeneous oesophago-gastric adenocarcinomas.Read the full paper here: bit.ly/1acACwz

    Nov 15,2013 10:02
80. 

    80. Gut podcast: Treatment of pancreatic fibrosis with siRNA

    Fibrosis associated with chronic pancreatitis is an irreversible lesion that can disrupt pancreatic exocrine and endocrine function. Currently, there are no approved treatments for this disease.In this podcast Mairi McLean, Gut education editor, talks to Professor Yoshiro Niitsu from Sapporo Medical University School of Medicine about his manuscript about the potential for therapeutic use of siRNA in the treatment of pancreatic fibrosis.Read the full research online:http://gut.bmj.com/content/62

    Oct 22,2013 13:16
81. 

    81. Intra-tumoural stroma as a predictor of survival in patients with gastric cancer

    Mairi McLean talks to Patrick Tan, associate professor, Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School Singapore, and Heike Grabsch, Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, University of Leeds, about their genomic meta-analysis to identify predictors of survival in patients with gastric cancer.See also: Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer http://goo.gl/Rw8lx6

    Aug 02,2013 17:21
82. 

    82. Probiotics in health and disease

    Mairi McLean talks to Emeran Mayer, Oppenheimer Center for Neurobiology of Stress, Division of Digestive Diseases, UCLA, about his paper: An update on the use and investigation of probiotics in health and disease.Read the full paper here: http://bit.ly/11ghKss

    Jul 25,2013 29:23
83. 

    83. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission

    In this podcast, Mairi McLean interviews Julián Panés and Azucena Salas, both from the Department of Gastroenterology, IDIBAPS, Hospital Clínic, CIBER-EHD in Barcelona, Spain. They disuse their recent article, looking at transcription in the intestinal mucosa of patients with ulcerative colitis.read the full article online: http://tinyurl.com/n3uy6d4

    Jul 25,2013 18:56
84. 

    84. mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway

    Mairi McLean talks to Philip Rosenstiel, Institute of Clinical Molecular Biology, Christian-Albrechts University, Kiel, and Stefan Schreiber, University Hospital Schleswig-Holstein, Kiel, about their paper: mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway: implications for Crohn’s disease http://bit.ly/11FU0Qw.

    Apr 24,2013 26:21
85. 

    85. Endoscopic improvement of mucosal lesions in patients with ileocolonic Crohn’s disease

    Mairi McLean, Gut’s education editor, talks to Xavier Hébuterne, Department of Gastroenterology and Nutrition, Archet Hospital, Nice, and Jean-Frédéric Colombel, Universite Lille Nord de France, about their paper: Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn’s disease following treatment with certolizumab pegol http://bit.ly/10dtab8.

    Apr 24,2013 23:07
86. 

    86. Bowel cancer screening in England

    Before the UK national bowel cancer screening programmes were implemented, a pilot was set-up in England to see if results from randomised controlled trials could be replicated in the general population. Gut has recently published findings from the third round of this.Co-author David Weller, Centre for Population Health Sciences–General Practice, University of Edinburgh, UK, talks to Gut’s associate editor William Grady about effectiveness of screening, uptake and its link to ethnicity, and the

    Feb 21,2013 20:59
87. 

    87. PUFAS and neoplasms

    Mairi McLean, Gut education editor, talks to Professor Mark Hull, Leeds Institute of Molecular Medicine, about his research into the action of polyunsaturated fatty acids on the formation of neoplams.See also:Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer (http://tinyurl.com/a7q8co4)

    Feb 21,2013 23:22
88. 

    88. Cancer treatment induced gastrointestinal symptoms

    In the UK chronic gastrointestinal symptoms after cancer therapies have a similar impact as IBD. However, in contrast to patients with IBD, most of these patients won’t see a gastroenterologist. In this month’s Gut Editor’s Choice the causes of these side effects of cancer treatment are discussed, as well as the benefits of investigation and treatment.In this podcast Mairi McLean, senior clinical lecturer and consultant in gastroenterology at the University of Aberdeen talks to some key stakehol

    Feb 21,2013 40:52
89. 

    89. Bifidobacterium and gastrointestinal inflammation

    Liam O’Mahony (Swiss Institute of Allergy and Asthma Research) talks to Mairi McLean (senior clinical lecturer and consultant in gastroenterology at the University of Aberdeen) about his paper looking at Bifidobacterium infantis’s interaction with T cells, and the bacterium’s potential to protect against gastrointestinal inflammation.See also:Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendr

    Feb 21,2013 16:43
90. 

    90. High-fat diet and gut microbiota

    Mairi Mclean, Gut’s education editor, talks to Matteo Serino from the Institut National de la Santé et de la Recherche Médicale (INSERM), about his article Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota (http://tinyurl.com/a4rdl2e), which is this month’s editor’s choice.

    Feb 21,2013 10:28
91. 

    91. Management of Helicobacter pylori infection

    Gut education editor Mairi Mclean talks to Professor Peter Malfertheiner, from the European Helicobacter Study Group, about the May editor’s choice paper: Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report.See also:Guidelines: Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report (http://tinyurl.com/bj2zn2g)

    Feb 21,2013 30:18
92. 

    92. Assessment of colorectal cancer molecular features

    Gut education editor Mairi Mclean talks to Dr Shuji Ogino, from Harvard Medical School, about his paper on the asessment of colorectal cancer molecular features.See also:Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum (http://tinyurl.com/bgs7o7u)

    Feb 21,2013 21:11
93. 

    93. Probiotic and postbiotic activity in health and disease

    Mairi Mclean (Gut education editor) talks to Maria Rescigno (European Institute of Oncology, Milan) about her editor’s choice paper - Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. (http://tinyurl.com/a8z4uqr)

    Feb 21,2013 15:30
94. 

    94. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

    Mairi McLean (Gut’s education editor) discusses August’s editor’s choice paper, on NKT-associated hedgehog and osteopontin and their role in non-alcoholic fatty liver disease, with authors Anna Mae Diehl (chief, Division of Gastroenterology, Duke University), Wing-Kin Syn (head of Regeneration and Repair, Institute of Hepatology, London) and Steve Choi (assistant professor, Division of Gastroenterology, Duke University).See also:NKT-associated hedgehog and osteopontin drive fibrogenesis in non-a

    Feb 21,2013 24:40
95. 

    95. Outcomes of the Bowel Cancer Screening Programme in England

    The Bowel Cancer Screening Programme has now been operating in England for six years, so how effective has it been in terms of take-up and detection? A paper in Gut examines the outcomes, and education editor Mairi McLean talks to some of the authors to hear what they found.See also:Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests (http://tinyurl.com/ax3cnlm)

    Feb 21,2013 20:59
96. 

    96. Mucosal healing in inflammatory bowel disease

    Recent studies have identified mucosal healing as a key prognostic parameter in the management of inflammatory bowel diseases. In this podcast Mairi McLean, education editor for Gut, talks to Marcus Neurath from the University of Erlangen-Nuremberg, and Simon Travis from John Radcliffe Hospital in Oxford, about their systematic review of the clinical studies on mucosal healing. They discuss the effects of anti-inflammatory or immunosuppressive drugs, and the implications of mucosal healing for s

    Feb 21,2013 21:23
97. 

    97. Interleukin 13 and its role in gut defence and inflammation

    Gut’s education editor Mairi McLean talks to Peter Mannon, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, and Walter Reinisch, Department of Medicine IV, Division Gastroenterology and Hepatology, Medical University of Vienna, about their research looking at interluekin 13 and its role in gut defence and inflammation.See also:Interleukin 13 and its role in gut defence and inflammation (http://tinyurl.com/akzwjxo)

    Feb 21,2013 30:35
98. 

    98. Revising the classification of acute pancreatitis

    Mairi McLean, Gut’s education editor, talks to Peter Banks, Division of Gastroenterology, Hepatology, and Endoscopy, Harvard Medical School, and Michael Sarr, Department of Surgery, Mayo Clinic, Rochester, about their revision of the Atlanta classification of acute pancreatitis.See also:Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus (http://tinyurl.com/arb6fg6)

    Feb 21,2013 31:08